Sean McLennan Net Worth

The estimated Net Worth of Sean Mc Lennan is at least $41.1 Tisíc dollars as of 16 June 2022. Mr Lennan owns over 30,000 units of Molecular Templates Inc stock worth over $41,100 and over the last 3 years he sold MTEM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr McLennan MTEM stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Molecular Templates Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 30,000 units of MTEM stock worth $24,600 on 16 June 2022.

The largest trade he's ever made was buying 30,000 units of Molecular Templates Inc stock on 16 June 2022 worth over $24,600. On average, Mr trades about 15,000 units every 0 days since 2022. As of 16 June 2022 he still owns at least 30,000 units of Molecular Templates Inc stock.

You can see the complete history of Mr Lennan stock trades at the bottom of the page.

Mr. Sean McLennan biography

Sean McLennan is the Sr. VP of Fin., Controller, Interim Principal Accounting Officer, Interim CFO & Treasurer at Molecular Templates Inc.

How old is Mr McLennan?

Mr McLennan is 50, he's been the Sr. VP of Fin., Controller, Interim Principal Accounting Officer a Interim CFO & Treasurer of Molecular Templates Inc since . There are 9 older and 10 younger executives at Molecular Templates Inc. The oldest executive at Molecular Templates Inc is David Hoffmann, 75, who is the Independent Director.

What's Mr McLennan's mailing address?

Sean's mailing address filed with the SEC is C/O MOLECULAR TEMPLATES, INC., 9301 AMBERGLEN BLVD., SUITE 100, AUSTIN, TX, 78729.

Insiders trading at Molecular Templates Inc

Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch a Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.

What does Molecular Templates Inc do?

molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.

Complete history of Mr Lennan stock trades at Molecular Templates Inc

Molecular Templates Inc executives and stock owners

Molecular Templates Inc executives and other stock owners filed with the SEC include:

• Eric Poma,
  Chief Executive Officer, Chief Scientific Officer, Director
• Roger Waltzman,
  Chief Medical Officer
• Jason Kim,
  President, Chief Operating Officer
• Adam Cutler,
  Chief Financial Officer, Treasurer, Secretary
• Dr. Eric E. Poma,
  CEO, Chief Scientific Officer & Director
• Dr. Roger J. Waltzman M.B.A., M.D.,
  Chief Medical Officer
• Jason S Kim,
  Pres & COO
• Dr. Roger J. Waltzman,
  Chief Medical Officer
• Corazon Sanders,
  Independent Director
• Harold Selick,
  Chairman of the Board
• Kevin Lalande,
  Independent Director
• David Hirsch,
  Independent Director
• David Hoffmann,
  Independent Director
• Scott Morenstein,
  Independent Director
• Jonathan Lanfear,
  Independent Director
• Michael Dowd,
  Sr. VP of Project & Alliance Management
• Megan C. Filoon,
  Gen. Counsel & Sec.
• Dr. Nenad Sarapa M.D., M.S.,
  Sr. VP of Clinical Devel.
• Dr. Jen-Sing Liu Ph.D.,
  Exec. VP of Manufacturing
• Dr. Erin Willert Ph.D.,
  Exec. VP of R&D
• Dr. Jack Higgins Ph.D.,
  Exec. VP of Operations & Head of Manufacturing
• Kurt Elster,
  Exec. VP of Corp. Devel.
• Sean McLennan,
  Sr. VP of Fin., Controller, Interim Principal Accounting Officer, Interim CFO & Treasurer
• Associates, L.L.C.Morenstei...,
  
• Target N Vbb Biotech Ag Bio...,
  
• Dave Hoffmann,
  Director
• Capital Partners Iii, Llc L...,
  
• Scott Dcdk Associates, L.L....,
  
• Management Services, Llc Cu...,
  
• Sean Mc Lennan,
  See remarks
• Management Services, Llc Cu...,
  
• Gabriela Gruia,
  Director
• Maurizio Voi,
  Chief Medical Officer